Zhong Guo Ji Jin Bao·2025-07-25 02:55Market Overview - The A-share market experienced fluctuations with the Shanghai Composite Index down by 0.21%, the Shenzhen Component Index down by 0.11%, and the ChiNext Index down by 0.09% as of July 25 [2] - The innovative drug sector showed strong performance, while AI application sectors experienced volatility, with internet, education, and virtual human sectors also being active [4] Sector Performance - The CRO concept stocks remained active, with notable gains from Kanglong Chemical (up 11.66%), Boteng Co. (up 10.68%), and others [8] - The healthcare, biotechnology, and pharmaceutical sectors saw upward movements, with Kangtai Medical reaching a 20% limit up, and several other companies hitting their upper limits [9] AI Application Sector - AI application stocks saw a rise, with ChatGPT-related stocks performing well; Yuncong Technology increased by over 11%, and Hanwang Technology hit the daily limit up [11] - The upcoming World Artificial Intelligence Conference on July 26 is expected to showcase over 3,000 cutting-edge exhibits, including numerous AI models and products, marking a record scale for the event [13] Regulatory and Market Insights - The National Medical Products Administration reported that 43 innovative drugs were approved in the first half of the year, a 59% increase year-on-year, nearing the total expected approvals for 2024 [10] - The R&D pipeline for innovative drugs in China accounts for approximately 25% of the global total, with around 3,000 projects undergoing clinical trials annually [10] AI Development Trends - According to CITIC Securities, since the release of ChatGPT, large models are evolving towards greater efficiency and reliability, with a shift in AI computing power consumption from training to inference, highlighting a trend towards self-controlled computing power in China [14]